infants. Pediatrics. 2011;127:635.
transfusions in preterm infants. J Perinatol. 2011;31:176.
infants?. J Pediatr. 2010;157:972.
20. Jain R, Jarosz C. Safety and efficacy of AS-1 red blood cell use in
neonates. Transfus Apher Sci. 2001;24:111.
21. Luban NL, Strauss RG, Hume HA. Commentary on the safety of
red cells preserved in extended-storage media for neonatal transfusions. Transfusion. 1991;31:229.
22. Strauss RG, Burmeister LF, Johnson K, et al. Feasibility and safety
of AS-3 red blood cells for neonatal transfusions. J Pediatr.
23. Luban NL. Massive transfusion in the neonate. Transfus Med Rev.
24. Pisciotto PT, Luban NLC. Complications of Neonatal
Transfusion. In: Popovsky MA, eds. Transfusion Reactions. 3rd ed.
Bethesda, MD: American Association of Blood Banks Press;
25. Luban NL. Neonatal red blood cell transfusions. Vox Sang.
preserved split red blood cell packs. J Perinatol. 2001;21:363.
27. Luban NL, Mikesell G, Sacher RA. Techniques for warming red
blood cells packaged in different containers for neonatal use. Clin
28. Strauss RG, Bell EF, Snyder EL, et al. Effects of environmental
warming on blood components dispensed in syringes for neonatal
transfusions. J Pediatr. 1986;109:109.
29. Blood components. In: Gottschall J, eds. Blood Transfusion
Therapy: A Physician’s Handbook. 8th ed. Bethesda, MD: American
Association of Blood Banks; 2005.
30. Fasano RM, Luban NL. Blood Component Therapy for the
Neonate. In: Martin R, Fanaroff A, eds. Fanaroff & Martin’s
Neonatal-Perinatal Medicine. 9th ed. St. Louis: Elsevier; 2010:
No comments:
Post a Comment